SUBJECTS : Kidney Cancer | Renal Cell Carcinoma | Renal Cance
LATEST MANUSCRIPTS IN Kidney Cancer
- Akanksha Sharma, Roy Elias, Alana Christie, Noelle S Williams, Ivan Pedrosa, Georg A Bjarnason, James Brugarolas. Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma. Kidney cancer (Clifton, Va.). 2023, 7 (1): 15
Cited : 0Read More - Nicholas R Schindler, David A Braun. Antigenic targets in clear cell renal cell carcinoma. Kidney cancer (Clifton, Va.). 2023, 7 (1): 81-91Cited : 0Read More
- Shuchi Gulati, Primo Nery Lara. Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor. Kidney cancer (Clifton, Va.). 2022, 6 (4): 201-203Cited : 1Read More
- Mamta Parikh, Primo N Lara. Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer. Kidney cancer (Clifton, Va.). 2022, 6 (2): 105-107Cited : 3Read More
- Ana Filipa Palma Dos Reis, Diana Simão, Thomas Odeny, Chiara Rodrigues, Mário Fontes-Sousa, Ricardo da Luz, Rajasree Pia Chowdry, Sarah J Welsh, Channing Paller, Pedro C Barata. A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer. Kidney cancer (Clifton, Va.). 2022, 6 (2): 115-127Cited : 2Read More
- Akanksha Sharma, Roy Elias, Alana Christie, Noelle S Williams, Ivan Pedrosa, Georg A Bjarnason, James Brugarolas. Extended disease control with unconventional cabozantinib dose increase in metastatic renal cell carcinoma. Kidney cancer (Clifton, Va.). 2022, 6 (1): 69-79Cited : 2Read More
- Lauren E Wilson, Lisa Spees, Jessica Pritchard, Melissa A Greiner, Charles D Scales, Christopher D Baggett, Deborah Kaye, Daniel J George, Tian Zhang, Stephanie B Wheeler, Michaela A Dinan. Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States. Kidney cancer (Clifton, Va.). 2021, 5 (3): 115-127Cited : 7Read More
- Marc Dall'Era, Primo N Lara. Defining the Optimal Management Strategy for Small Renal Masses. Kidney cancer (Clifton, Va.). 2021, 5 (3): 137-138Cited : 1Read More
- Sabrina Salgia, Nicholas Salgia, Sweta Prajapati, Ishaan Seghal, Frank Bautista, Nora Ruel, Meghan Salgia, Deborah A Salgia, Ravi Salgia, Sumanta K Pal. Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic. Kidney cancer (Clifton, Va.). 2021, 5 (2): 73-78Cited : 1Read More
- Jennifer J Huang, James J Hsieh. The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice. Kidney cancer (Clifton, Va.). 2020, 4 (3): 121-129Cited : 2Read More
- Chelsea K Osterman, Allison M Deal, Matthew I Milowsky, Marc A Bjurlin, Tracy L Rose. Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma. Kidney cancer (Clifton, Va.). 2020, 4 (3): 131-137Cited : 3Read More
- Chelsea K Osterman, Tracy L Rose. A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma. Kidney cancer (Clifton, Va.). 2020, 4 (1): 15-27Cited : 7Read More
- Michael Siev, Audrey Renson, Hung-Jui Tan, Tracy L Rose, Stella K Kang, William C Huang, Marc A Bjurlin. Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers. Kidney cancer (Clifton, Va.). 2020, 4 (1): 49-58Cited : 3Read More
- Katherine Emilie Rhoades Smith, Mehmet Asim Bilen. A Review of Papillary Renal Cell Carcinoma and MET Inhibitors. Kidney cancer (Clifton, Va.). 2019, 3 (3): 151-161Cited : 42Read More
- Timothy W Synold, Melissa Plets, Catherine M Tangen, Elisabeth I Heath, Ganesh S Palapattu, Philip C Mack, Mark N Stein, Maxwell V Meng, Primo Lara, Nicholas J Vogelzang, Ian Murchie Thompson, Christopher W Ryan. Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249). Kidney cancer (Clifton, Va.). 2019, 3 (2): 111-118Cited : 11Read More
